TP53 and steatosis: According to these results, TP53 activation may be a widespread metabolic process that plays a significant role in the pathogenesis of fatty liver, regardless of the underlying cause, and that promotes apoptosis and oxidative stress and the development of harmful hepatic abnormalities like insulin resistance and steatosis.